EE04677B1 - Tetrahdropridoeetrid, nende kasutamine ja ravim - Google Patents
Tetrahdropridoeetrid, nende kasutamine ja ravimInfo
- Publication number
- EE04677B1 EE04677B1 EEP200100172A EEP200100172A EE04677B1 EE 04677 B1 EE04677 B1 EE 04677B1 EE P200100172 A EEP200100172 A EE P200100172A EE P200100172 A EEP200100172 A EE P200100172A EE 04677 B1 EE04677 B1 EE 04677B1
- Authority
- EE
- Estonia
- Prior art keywords
- ridoethers
- tetrah
- medicine
- drop
- naphthyridine
- Prior art date
Links
- 239000003814 drug Substances 0.000 title 1
- PWILYDZRJORZDR-MISYRCLQSA-N (7r,8r,9r)-7-(2-methoxyethoxy)-2,3-dimethyl-9-phenyl-7,8,9,10-tetrahydroimidazo[1,2-h][1,7]naphthyridin-8-ol Chemical compound C1([C@@H]2[C@@H](O)[C@@H](C3=C(C4=NC(C)=C(C)N4C=C3)N2)OCCOC)=CC=CC=C1 PWILYDZRJORZDR-MISYRCLQSA-N 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 210000004211 gastric acid Anatomy 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4375—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a six-membered ring having nitrogen as a ring heteroatom, e.g. quinolizines, naphthyridines, berberine, vincamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyridine Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP98117988 | 1998-09-23 | ||
| DE19843504 | 1998-09-23 | ||
| PCT/EP1999/006899 WO2000017200A1 (en) | 1998-09-23 | 1999-09-17 | Tetrahydropyridoethers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| EE200100172A EE200100172A (et) | 2002-06-17 |
| EE04677B1 true EE04677B1 (et) | 2006-08-15 |
Family
ID=26049024
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200100172A EE04677B1 (et) | 1998-09-23 | 1999-09-17 | Tetrahdropridoeetrid, nende kasutamine ja ravim |
Country Status (31)
| Country | Link |
|---|---|
| US (4) | US6436953B1 (cs) |
| EP (1) | EP1115725B1 (cs) |
| JP (1) | JP4145492B2 (cs) |
| KR (1) | KR100668400B1 (cs) |
| CN (2) | CN1155598C (cs) |
| AT (1) | ATE231862T1 (cs) |
| AU (1) | AU763463B2 (cs) |
| BG (1) | BG65195B1 (cs) |
| BR (1) | BR9914044A (cs) |
| CA (1) | CA2344251A1 (cs) |
| CZ (1) | CZ292335B6 (cs) |
| DE (1) | DE69905178T2 (cs) |
| DK (1) | DK1115725T3 (cs) |
| EA (1) | EA005377B1 (cs) |
| EE (1) | EE04677B1 (cs) |
| ES (1) | ES2191464T3 (cs) |
| GE (1) | GEP20032926B (cs) |
| HK (1) | HK1038360B (cs) |
| HR (1) | HRP20010224A2 (cs) |
| HU (1) | HUP0102990A3 (cs) |
| ID (1) | ID28896A (cs) |
| IL (2) | IL142063A0 (cs) |
| NO (1) | NO317304B1 (cs) |
| NZ (1) | NZ510610A (cs) |
| PL (1) | PL193616B1 (cs) |
| PT (1) | PT1115725E (cs) |
| RS (1) | RS50145B (cs) |
| SI (1) | SI1115725T1 (cs) |
| SK (1) | SK285165B6 (cs) |
| TR (1) | TR200100805T2 (cs) |
| WO (1) | WO2000017200A1 (cs) |
Families Citing this family (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| HUP0102990A3 (en) | 1998-09-23 | 2002-09-30 | Altana Pharma Ag | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof |
| EP1173439B1 (en) | 1999-04-17 | 2003-05-21 | ALTANA Pharma AG | Haloalkoxy imidazonaphthyridines |
| CA2285516C (en) * | 1999-05-12 | 2010-12-07 | President And Fellows Of Harvard College | Dopamine transporter imaging agents |
| MXPA02009551A (es) * | 2000-03-29 | 2004-05-14 | Altana Pharma Ag | Profarmacos de derivados de imidazopiridina. |
| ATE356131T1 (de) * | 2000-03-29 | 2007-03-15 | Altana Pharma Ag | Tricyclische imidazopyridine |
| HUP0302308A2 (hu) * | 2000-10-25 | 2003-11-28 | Altana Pharma Ag | Többszörösen helyettesített imidazo-piridinek mint gyomorsavkiválasztás-gátlók és ezeket tartalmazó gyógyszerkészítmények |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| EP1370261A2 (en) * | 2001-03-08 | 2003-12-17 | AstraZeneca AB | New use |
| JP2005500372A (ja) | 2001-08-02 | 2005-01-06 | アルタナ ファルマ アクチエンゲゼルシャフト | 三環エポキシド |
| EP1417208A1 (en) * | 2001-08-03 | 2004-05-12 | ALTANA Pharma AG | Amino-substituted imidazopyridines for the treatment of gastrointestinal diseases |
| NZ531433A (en) * | 2001-08-03 | 2005-09-30 | Altana Pharma Ag | Alkyl-substituted imidazopyridines for the treatment of gastrointestinal disorders |
| HRP20040834A2 (en) | 2002-02-15 | 2005-06-30 | Altana Pharma Ag | Tricyclic n-acyl compounds |
| MY140561A (en) * | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| CA2484272A1 (en) * | 2002-05-07 | 2003-11-20 | Altana Pharma Ag | New combination of reversible proton pump inhibitors and airway therapeutics for treating airway disorders |
| EA008304B1 (ru) | 2002-11-19 | 2007-04-27 | Алтана Фарма Аг | 8-замещённые имидазопиридины |
| DK1572217T3 (da) | 2002-12-12 | 2008-12-15 | Nycomed Gmbh | Kombinationsmedikament af R,R-formoterol og ciclesonid |
| CN1726031A (zh) * | 2002-12-20 | 2006-01-25 | 奥坦纳医药公司 | 8－三烷基硅氧基－2－甲基－9－苯基－7－氧代－7,8,9,10－四氢咪唑并[1,2－h][1,7]二氮杂萘 |
| EP1599175A2 (en) * | 2003-02-17 | 2005-11-30 | ALTANA Pharma AG | Imidazopyridines containing combinations and their use in treating gastrointestinal inflammatory disorders |
| US7470791B2 (en) | 2003-03-10 | 2008-12-30 | Nycomed Gmbh | Process for the preparation of roflumilast |
| TW200503783A (en) * | 2003-04-11 | 2005-02-01 | Altana Pharma Ag | Oral pharmaceutical preparation for proton pump antagonists |
| SA04250092B1 (ar) * | 2003-05-14 | 2008-05-04 | التانا فاروا ايه جي | مركب وسيط جديد لتحضير مركبات إيميدازوبيريدين imidazopyridines فعالة علاجياً |
| RS20050868A (en) * | 2003-05-27 | 2007-08-03 | Altana Pharma Ag., | Pharmaceutical combinations of a proton pump inhibitor and a compound which modifies gastrointestinal motility |
| AU2004268641A1 (en) * | 2003-08-29 | 2005-03-10 | Dynogen Pharmaceuticals, Inc. | Compositions useful for treating gastrointestinal motility disorders |
| DK1670482T4 (da) | 2003-09-16 | 2022-08-22 | Covis Pharma B V | Anvendelse af ciclesonid til behandlingen af respiratoriske sygdomme |
| US20080280944A1 (en) * | 2003-11-03 | 2008-11-13 | Paula Fernstrom | Imidazo[1,2-A]Pyridine Derivatives For The Treatment Of Silent Gastro-Esophageal Reflux |
| CA2549860A1 (en) | 2003-12-19 | 2005-06-30 | Altana Pharma Ag | Intermediates for the preparation of tricyclic dihydropyrano -imidazo -pyridines derivatives |
| AR047605A1 (es) * | 2004-02-17 | 2006-01-25 | Altana Pharma Ag | Imidazopiridinas triciclicas e intermediarios en la sintesis de las mismas,sus procesos de preparacion,composiciones farmaceuticas que los contienen y usos. |
| CN101018789B (zh) | 2004-09-03 | 2010-09-08 | 株式会社柳韩洋行 | 吡咯并[2,3-c]吡啶衍生物及其制备方法 |
| WO2006025714A1 (en) | 2004-09-03 | 2006-03-09 | Yuhan Corporation | PYRROLO[3,2-c]PYRIDINE DERIVATIVES AND PROCESSES FOR THE PREPARATION THEREOF |
| DK1784403T3 (da) | 2004-09-03 | 2013-10-21 | Yuhan Corp | Pyrrolo[3,2-b]pyridinderivater samt fremgangsmåder til deres fremstilling |
| CA2601250C (en) * | 2005-03-16 | 2014-10-28 | Nycomed Gmbh | Taste masked dosage form containing roflumilast |
| EP2080513A1 (en) | 2008-01-16 | 2009-07-22 | Schraermeyer, Ulrich, Prof. Dr. rer. nat | Tetrahydropyridoethers for treatment of AMD |
| EP2452680B1 (en) | 2009-07-09 | 2019-12-18 | RaQualia Pharma Inc. | Acid pump antagonist for the treatment of diseases involved in abnormal gastrointestinal motility |
| WO2012027240A1 (en) * | 2010-08-23 | 2012-03-01 | Schering Corporation | Fused tricyclic inhibitors of mammalian target of rapamycin |
| CA2874988C (en) * | 2012-06-15 | 2016-05-24 | Bio-Pharm Solutions Co., Ltd. | Phenylalkyl sulfamate compound and muscle relaxant composition comprising the same |
| US20160235724A1 (en) | 2013-10-08 | 2016-08-18 | Katairo Gmbh | Tetrahydropyridoethers for the treatment of stargardt's disease |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4468400A (en) * | 1982-12-20 | 1984-08-28 | Schering Corporation | Antiulcer tricyclic imidazo [1,2-a]pyridines |
| US5112834A (en) | 1987-07-16 | 1992-05-12 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Imidazole protectorant for the stomach and intestine |
| SE9401197D0 (sv) * | 1994-04-11 | 1994-04-11 | Astra Ab | Active compounds |
| WO1996003404A1 (de) * | 1994-07-28 | 1996-02-08 | Byk Gulden Lomberg Chemische Fabrik Gmbh | Acylimidazopyridine |
| AU740578B2 (en) * | 1997-03-24 | 2001-11-08 | Altana Pharma Ag | Tetrahydropyrido compounds |
| EP0971922B1 (en) * | 1997-03-24 | 2004-04-28 | ALTANA Pharma AG | Tetrahydropyrido compounds |
| HUP0102990A3 (en) | 1998-09-23 | 2002-09-30 | Altana Pharma Ag | Tetrahydroimidazo-naphtyridine derivatives and pharmaceutical compositions thereof |
-
1999
- 1999-09-17 HU HU0102990A patent/HUP0102990A3/hu unknown
- 1999-09-17 BR BR9914044-6A patent/BR9914044A/pt not_active Application Discontinuation
- 1999-09-17 TR TR2001/00805T patent/TR200100805T2/xx unknown
- 1999-09-17 HK HK02100042.6A patent/HK1038360B/en not_active IP Right Cessation
- 1999-09-17 KR KR1020017003553A patent/KR100668400B1/ko not_active Expired - Fee Related
- 1999-09-17 PL PL99346617A patent/PL193616B1/pl not_active IP Right Cessation
- 1999-09-17 DK DK99948776T patent/DK1115725T3/da active
- 1999-09-17 EP EP99948776A patent/EP1115725B1/en not_active Expired - Lifetime
- 1999-09-17 SI SI9930207T patent/SI1115725T1/xx unknown
- 1999-09-17 RS YUP-214/01A patent/RS50145B/sr unknown
- 1999-09-17 NZ NZ510610A patent/NZ510610A/en unknown
- 1999-09-17 SK SK399-2001A patent/SK285165B6/sk not_active IP Right Cessation
- 1999-09-17 ES ES99948776T patent/ES2191464T3/es not_active Expired - Lifetime
- 1999-09-17 CN CNB998112992A patent/CN1155598C/zh not_active Expired - Fee Related
- 1999-09-17 EE EEP200100172A patent/EE04677B1/xx not_active IP Right Cessation
- 1999-09-17 ID IDW20010682A patent/ID28896A/id unknown
- 1999-09-17 AT AT99948776T patent/ATE231862T1/de not_active IP Right Cessation
- 1999-09-17 US US09/582,212 patent/US6436953B1/en not_active Expired - Lifetime
- 1999-09-17 WO PCT/EP1999/006899 patent/WO2000017200A1/en active IP Right Grant
- 1999-09-17 CN CNB2004100384351A patent/CN100506821C/zh not_active Expired - Fee Related
- 1999-09-17 AU AU61920/99A patent/AU763463B2/en not_active Expired
- 1999-09-17 IL IL14206399A patent/IL142063A0/xx active IP Right Grant
- 1999-09-17 PT PT99948776T patent/PT1115725E/pt unknown
- 1999-09-17 JP JP2000574109A patent/JP4145492B2/ja not_active Expired - Lifetime
- 1999-09-17 CA CA002344251A patent/CA2344251A1/en not_active Abandoned
- 1999-09-17 EA EA200100315A patent/EA005377B1/ru not_active IP Right Cessation
- 1999-09-17 DE DE69905178T patent/DE69905178T2/de not_active Expired - Lifetime
- 1999-09-17 CZ CZ20011082A patent/CZ292335B6/cs not_active IP Right Cessation
- 1999-09-17 GE GEAP19995786A patent/GEP20032926B/en unknown
- 1999-09-17 HR HR20010224A patent/HRP20010224A2/hr not_active Application Discontinuation
-
2001
- 2001-02-19 BG BG105270A patent/BG65195B1/bg unknown
- 2001-03-12 NO NO20011243A patent/NO317304B1/no not_active IP Right Cessation
- 2001-03-18 IL IL142063A patent/IL142063A/en not_active IP Right Cessation
-
2002
- 2002-03-25 US US10/103,733 patent/US6696460B2/en not_active Expired - Lifetime
-
2004
- 2004-02-23 US US10/783,512 patent/US7105676B2/en not_active Expired - Lifetime
-
2006
- 2006-07-27 US US11/493,707 patent/US7393860B1/en not_active Expired - Fee Related
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE04677B1 (et) | Tetrahdropridoeetrid, nende kasutamine ja ravim | |
| EE04800B1 (et) | Oraalne manustamisvorm happes ebapüsiva toimeainetarbeks, toimeaineühik, selle valmistamismeetod ja kasutamine ning meetod oraalse manustamisvormi valmistamiseks | |
| FI974440A0 (fi) | Bifenyyli-2-karboksyylihappo-tetrahydro-isokinolin-6-yyli-amidijohdannaisia, niiden valmistus ja niiden käyttö mikrosomaalistatriglyseridiä siirtävän proteiinin ja/tai apolipoproteiini B:n (Apo B) erittymiseen inhibiittoreina | |
| NO961006L (no) | Fosfonomononukleinsyrer, fremgangsmåter for fremstilling derav og anvendelse av forbindelsene | |
| FI963298L (fi) | Hydrokseemihappo- ja karboksyylihappojohdannaisia, menetelmä niiden valmistamiseksi ja niiden käyttö | |
| FI971529L (fi) | Uudet karboksyylihappojohdannaiset, niiden valmistus ja käyttö | |
| DE10299001I1 (de) | Erythromycinderivate, ihre Verfahren zur Herstellung und ihre Verwendung als Arzneimittel. | |
| DK0914119T3 (da) | Fremgangsmåde til fremstilling af faste orale dosisformer af valsartan | |
| EE9900441A (et) | Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nende solvaatide suu kaudu manustamiseks | |
| EE03568B1 (et) | Bensimidasooli derivaadid, nende valmistamismeetod ja kasutamine | |
| EE04060B1 (et) | Heterotsüklilised ühendid maohappesekretsiooni inhibeerimiseks, protsess nende valmistamiseks ja ravimkoostised | |
| NO882472D0 (no) | Fremgangsmaate for fremstilling av peptidborsyreinhibitorer for trypsinlignende proteaser. | |
| NO911934D0 (no) | Fremgangsmaate for fremstilling av bicykliske 1-aza-cykloalkaner. | |
| EE9800302A (et) | Arüülglütsiinamiidi derivaadid, nende valmistamismeetod ja kasutamine ning farmatseutiline preparaat | |
| FI990134A0 (fi) | Pyridatsino-(4,5-beta)-kinoliini-5-oksidijohdannaisia, niiden valmistus ja niiden käyttö glysiiniantagonisteina | |
| TR199600779A2 (tr) | Imidazo benzodiazepin türevlerinin imal edilmesine mahsus yöntem. | |
| ATE242242T1 (de) | Derivate von imidazo(1,2-a)pyridin zur behandlung von gastrointestinalen krankheiten | |
| CY1106376T1 (el) | Δικυκλικα παραγωγα των αμινο-πυραζινονων, μεθοδος παρασκευης τους και οι φαρμακευτικες συνθεσεις που τα πepιεχουν | |
| AU7788500A (en) | Use of substance p antagonists for influencing the circadian timing system | |
| IS2199B (is) | Svæfandi ß-karbólín afleiður, aðferð til framleiðslu þeirra og notkun þeirra sem læknislyf | |
| NO20003454L (no) | FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4- | |
| TR199800403A3 (tr) | a-Bromo-laktam türevlerinin hazirlanmasi için yöntem. | |
| EE200000537A (et) | Pürasolo[4,3-d]pürimidiin-7-oon-3-püridüülsulfonüülühendite ja nende vaheühendite valmistamise protsess | |
| DE59708511D1 (de) | Verwendung von 7-(1-aminomethyl-2-oxa-7-aza-bicyclo 3.3.0]oct-7-yl)-chinoloncarbonsäure- und -naphthyridoncarbonsäure-derivaten zur therapie von helicobacter-pylori-infektionen und den damit assoziierten gastroduodenalen erkrankungen | |
| DE69719190D1 (de) | Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB4A | Valid patent at the end of a year |
Effective date: 20061231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20071231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20081231 |
|
| KB4A | Valid patent at the end of a year |
Effective date: 20101231 |
|
| MM4A | Lapsed by not paying the annual fees |
Effective date: 20100917 |